⸺ Synova Research
CJC-1295 DAC
Long-acting GHRH analogue with a drug affinity complex, studied for sustained growth hormone signalling in preclinical models.
Secure checkout via UK open banking. Free shipping on orders over £100.
Independently tested
COA on request
Next-day UK dispatch
Order before midnight
Research use only
Not for human consumption
⸺ Important
- • Peptides sold in lyophilized form
- • Strictly for laboratory research
⸺ Overview
About CJC-1295 DAC
CJC-1295 with DAC binds to serum albumin, greatly extending its half-life compared with the no-DAC form. Researchers use it to study prolonged elevation of growth hormone and IGF-1 in animal models.
⸺ Mechanism of Action
How it works
The drug affinity complex attaches the peptide to albumin in the bloodstream, slowing clearance. It continues to stimulate pituitary GHRH receptors over several days, producing a sustained rise in growth hormone rather than a single pulse.
⸺ Research
Areas of study
Sustained GH and IGF-1
Animal studies report multi-day elevations in growth hormone and IGF-1 after a single administration.
Body composition models
Preclinical research examines lean mass and adipose tissue changes under prolonged GH signalling.
Dosing frequency studies
Researchers use the extended half-life to model infrequent-administration protocols in rodents.
Summarised from preclinical literature for informational purposes only. Not medical or veterinary advice. Synova Research products are sold strictly for in-vitro and laboratory research.
⸺ Details
Specification
- CAS
- 863288-34-0
- Intended use
- Research use only.
- Storage
- Lyophilised: cool, dry, dark. Reconstituted: refrigerate at 2–8°C.
- Solubility
- Vial holds up to 3mL.
- Shelf life
- Lyophilised: up to 24 months. Reconstituted: 4–6 weeks refrigerated.
- Handling
- Maintain sterile technique.
You might also research
View all →
R3TA
Investigational triple receptor agonist targeting GLP-1, GIP and glucagon — studied in animal models for appetite control, energy expenditure and glucose balance.
T1RZ
Dual GLP-1 and GIP receptor agonist studied in preclinical models for glucose regulation, insulin sensitivity and energy balance.
Semaglutide
Synthetic analogue of the GLP-1 hormone used in research to study glucose regulation, insulin secretion and the incretin response.